enCELL Master stands as a testament to research empowerment
- home
- Machines
- enCELL Pharm
enCELL Pharm
Elevating research to clinical scale, enCELL Pharm operates at a flow rate of 100 mL/min. Designed to meet the stringent demands of pharmaceutical applications, enCELL Pharm produces uniform particles tailored for targeted therapies and drug delivery systems. With enCELL Pharm, precision and efficiency converge to drive clinical advancements
- No need for separate scale-up process optimization
- Organic solvents like Ethanol, Acetone, and DMC can be used
- Acquire purchasing customers
Pfizer
- Impingement jet mixing in a small chamber developed by KNAUER
- mRNA-LNP production capability (100, 250, 500 ml/m)
moderna
- Diffusion mixing in a microchannel by Acuitas
- mRNA-LNP production capability (60, 90 ml/m)
- Acquire purchasing customers
- Scheduled continuous production of drug particles applied to Daegu Cheombok
- Continuous process development and preparation for mass production
Partner with Us for Microfluidics Excellence
Contact us today to explore how our microfluidics solutions can empower your pharmaceutical endeavors. Let’s shape the future of medicine together.
EnCell is trying to develop a clear and comprehensive sustainability strategy.
This strategy should outline the company's commitment to environmental stewardship, social responsibility, and economic viability. Our company's efforts, setting priorities, and driving continuous improvement towards a more sustainable microfluidics solution company.